Lim, S. K., Peng, C. C., Low, S., Vijay, V., Budiman, A., Phang, B. H., . . . Sciences, S. o. B. (2023). Sustained activation of non-canonical NF-κB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL.
استشهاد بنمط شيكاغوLim, Shen Kiat, et al. Sustained Activation of Non-canonical NF-κB Signalling Drives Glycolytic Reprogramming in Doxorubicin-resistant DLBCL. 2023.
MLA استشهادLim, Shen Kiat, et al. Sustained Activation of Non-canonical NF-κB Signalling Drives Glycolytic Reprogramming in Doxorubicin-resistant DLBCL. 2023.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.